RNA vaccines train the immune system in a similar way to traditional vaccines, but they use a different strategy to get there ...

Newton-Wellesley Hospital said five staff members who had worked on its fifth floor were diagnosed with brain tumors — none ...

Concern is growing among public health experts that anti-vaccine sentiments within federal and state governments may derail ...

We recently published a list of 10 Best Long Term Growth Stocks to Buy According to Billionaires. In this article, we are ...

Researchers at the University of Cologne have found that mRNA-based COVID-19 vaccines have a lasting impact on the innate ...

Discover how an emerging technology called tRNA therapy could become the next big thing in genetic disease treatment.

In a report released today, Terence Flynn from Morgan Stanley maintained a Hold rating on Moderna (MRNA – Research Report), with a price target ...

Shares of some U.S. biotechnology companies including Moderna (MRNA) plunged on Monday after reports that the top vaccine ...

A team of researchers led by Dr. Kim V. Narry, director of the Center for RNA Research at the Institute for Basic Science ...

In this article, we are going to take a look at where Moderna, Inc. (NASDAQ:MRNA) stands against other stocks that Jim Cramer ...

Heidelberg biochemists and structural biologists from Shanghai unravel the roles of two key regulatory factors in mRNA ...

Researchers have identified cellular factors that regulate the delivery and stability of mRNA to expand the potential of mRNA ...